NAV
$69.28
AUM
$3.1B
Expense Ratio
-
Dividend Yield
4.20%
Beta
0.57
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.42% | +6.83% | +11.59% | +21.94% | +8.95% | +5.78% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 15.81% |
| 2 | JNJ | Johnson & Johnson | 9.68% |
| 3 | ABBV | AbbVie Inc | 6.89% |
| 4 | UNH | UnitedHealth Group Inc | 6.18% |
| 5 | MRK | Merck & Co Inc | 5.27% |
| 6 | TMO | Thermo Fisher Scientific Inc | 3.32% |
| 7 | AMGN | Amgen Inc | 3.24% |
| 8 | GILD | Gilead Sciences Inc | 2.99% |
| 9 | ISRG | Intuitive Surgical Inc | 2.68% |
| 10 | PFE | Pfizer Inc | 2.66% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.
Inception Date: 2000-06-12